Mucosal immunization with polyamine transport protein D (PotD) protects mice against nasopharyngeal colonization with Streptococcus pneumoniae

Experimental Biology and Medicine

Volumn 234, Issue 4, 2009, Pages 403-409

  Shah, Pratik ^a   Briles, David E ^b,c   King, Janice ^b   Hale, Yvette ^b   Swiatlo, Edwin ^a,d  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b University of Alabama at Birmingham   (United States)

^c University of Alabama at Birmingham   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

PotD; Streptococcus pneumoniae; Vaccine

Indexed keywords

CHOLERA TOXIN B SUBUNIT; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; PNEUMOCOCCUS VACCINE; POLYAMINE TRANSPORT PROTEIN D; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COLONIZATION; BRAIN; CONTROLLED STUDY; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; MUCOSAL IMMUNITY; NASOPHARYNX; NONHUMAN; OLFACTORY BULB; PNEUMOCOCCAL INFECTION; SEROTYPE; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODY FORMATION; BACTERIAL PROTEINS; CHOLERA TOXIN; IMMUNIZATION; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MEMBRANE TRANSPORT PROTEINS; MICE; NASAL MUCOSA; NASOPHARYNX; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; STREPTOCOCCUS PNEUMONIAE;

ANIMALIA; MURINAE; MUS; STREPTOCOCCUS PNEUMONIAE;

EID: 66449128812     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.3181/0809-RM-269     Document Type: Article

References (46)

1. Fedson DS, Scott JA. The burden of pneumococcal disease among adults in developed and developing countries: what is and is not known. Vaccine 17 Suppl 1:S11-18, 1999. (Pubitemid 29366927)
2. WHO. Pneumococcal vaccines. World Health Organization position paper. Wkly Epidemiol Rec 74:177-183, 1999.
3. Fedson DS. The clinical effectiveness of pneumococcal vaccination: a brief review. Vaccine 17:S85-S90, 1999. (Pubitemid 29366941)
4. Eskola J. Immunogenicity of pneumococcal conjugate vaccines. Pediatr Infect Dis J 19:388-393, 2000. (Pubitemid 30213091)
5. Moore MR, Whitney CG. Emergence of nonvaccine serotypes following introduction of pneumococcal conjugate vaccine: cause and effect? Clin Infect Dis 46:183-185, 2008.
6. Swiatlo E, Ware D. Novel vaccine strategies with protein antigens of Streptococcus pneumoniae. FEMS Immunol Med Microbiol 38:1-7, 2003. (Pubitemid 37297436)
7. Alexander JE, Lock RA, Peeters CCAM, Poolman JT, Andrew PW, Mitchell TJ, Hansman D, Paton JC. Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniae. Infect Immun 62: 5683-5688, 1994. (Pubitemid 24365020)
8. Balachandran P, Brooks-Walter A, Virolainen-Julkunen A, Hollingshead SK, Briles DE. Role of pneumococcal surface protein C in nasopharyngeal carriage and pneumonia and its ability to elicit protection against carriage of Streptococcus pneumoniae. Infect Immun 70:2526-2534, 2002.
9. Briles DE, Ades E, Paton JC, Sampson JS, Carlone GM, Huebner RC, Virolainen A, Swiatlo E, Hollingshead SK. Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae. Infect Immun 68:796-800, 2000. (Pubitemid 30056538)
10. Brown JS, Ogunniyi AD, Woodrow MC, Holden DW, Paton JC. Immunization with components of two iron uptake ABC transporters protects mice against systemic Streptococcus pneumoniae infection. Infect Immun 69:6702-6706, 2001. (Pubitemid 32995427)
11. Green BA, Zhang Y, Masi AW, Barniak V, Wetherell M, Smith RP, Reddy MS, Zhu D. PppA, a surface-exposed protein of Streptococcus pneumoniae, elicits cross-reactive antibodies that reduce colonization in a murine intranasal immunization and challenge model. Infect Immun 73:981-989, 2005. (Pubitemid 40165758)
12. Shah P, Swiatlo E. Immunization with polyamine transport protein PotD protects mice against systemic infection with Streptococcus pneumoniae. Infect Immun 74:5888-5892, 2006. (Pubitemid 44484576)
13. Zhang Y, Masi AW, Barniak V, Mountzouros K, Hostetter MK, Green BA. Recombinant PhpA protein, a unique histidine motif-containing protein from Streptococcus pneumoniae, protects mice against intranasal pneumococcal challenge. Infect Immun 69:3827-3836, 2001. (Pubitemid 32493302)
14. Glover DT, Hollingshead SK, Briles DE. Streptococcus pneumoniae surface protein PcpA elicits protection against lung infection and fatal sepsis. Infect Immun 76(6):2767-2776, 2008.
15. Ogunniyi AD, Grabowicz M, Briles DE, Cook J, Paton JC. Development of a vaccine against invasive pneumococcal disease based on combinations of virulence proteins of Streptococcus pneumoniae. Infect Immun 75:350-357, 2007. (Pubitemid 46047911)
16. Briles DE, Hollingshead S, Brooks-Walter A, Nabors GS, Ferguson L, Schilling M, Gravenstein S, Braun P, King J, Swift A. The potential to use PspA and other pneumococcal proteins to elicit protection against pneumococcal infection. Vaccine 18:1707-1711, 2000. (Pubitemid 30109533)
17. Briles DE, Hollingshead SK, Paton JC, Ades EW, Novak L, van Ginkel FW, Benjamin WH Jr. Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae. J Infect Dis 188:339-348, 2003. (Pubitemid 36966099)
18. Shah P, Swiatlo E. A multifaceted role for polyamines in bacterial pathogens. Molecular Microbiology 68:4-16, 2008.
19. Igarashi K, Kashiwagi K. Polyamine transport in bacteria and yeast. Biochem J 344 Pt 3:633-642, 1999. (Pubitemid 30032511)
20. Ware D, Watt J, Swiatlo E. Utilization of putrescine by Streptococcus pneumoniae during growth in choline-limited medium. J Microbiol 43: 398-405, 2005. (Pubitemid 41666878)
21. Shah P, Marquart M, Quin LR, Swiatlo E. Cellular location of polyamine transport protein PotD in Streptococcus pneumoniae. FEMS Microbiol Lett 261:235-237, 2006. (Pubitemid 44134158)
22. Polissi A, Pontiggia A, Feger G, Altieri M, Mottl H, Ferrari L, Simon D. Large-scale identification of virulence genes from Streptococcus pneumoniae. Infect Immun 66:5620-5629, 1998. (Pubitemid 28531814)
23. Ware D, Jiang Y, Lin W, Swiatlo E. Involvement of potD in Streptococcus pneumoniae polyamine transport and pathogenesis. Infect Immun 74:352-361, 2006. (Pubitemid 43023091)
24. Shah P, Romero DG, Swiatlo E. Role of polyamine transport in Streptococcus pneumoniae response to physiological stress and murine septicemia. Microb Pathog 45:167-172, 2008.
25. Tettelin H, Nelson KE, Paulsen IT, Eisen JA, et al. Complete genome sequence of a virulent isolate of Streptococcus pneumoniae. Science 293:498-506, 2001. (Pubitemid 32679078)
26. Wu H-Y, Virolainen A, Mathews B, King J, Russell MW, Briles DE. Establishment of a Streptococcus pneumoniae nasopharyngeal colonization model in adult mice. Microb Pathog 23:127-137, 1997.
27. Briles DE, Tart RC, Wu HY, Ralph BA, Russell MW, McDaniel LS. Systemic and mucosal protective immunity to pneumococcal surface protein A. Ann N Y Acad Sci 797:118-126, 1996. (Pubitemid 27055585)
28. van Ginkel FW, McGhee JR, Watt JM, Campos-Torres A, Parish LA, Briles DE. Pneumococcal carriage results in ganglioside-mediated olfactory tissue infection. Proc Natl Acad Sci U S A 100:14363-14367, 2003. (Pubitemid 37499242)
29. Briles DE, Crain MJ, Gray BM, Forman C, Yother J. Strong association between capsular type and virulence for mice among human isolates of Streptococcus pneumoniae. Infect Immun 60:111-116, 1992.
30. Briles DE, Hollingshead SK, Paton JC, Ades EW, Novak L, van Ginkel FW, Benjamin WH. Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae. J Infect Dis 188:339-348, 2003. (Pubitemid 36966099)
31. Boulnois GJ. Pneumococcal proteins and the pathogenesis of disease caused by Streptococcus pneumoniae. J Gen Microbiol 138:249-259, 1992.
32. Musher DM. Infections caused by Streptococcus pneumoniae: clinical spectrum, pathogenesis, immunity, and treatment. Clin Infect Dis 14: 801-809, 1992.
33. Stenfors LE, Raisanen S. Abundant attachment of bacteria to nasopharyngeal epithelium in otitis-prone children. J Infect Dis 165: 1148-1150, 1992.
34. Garmory HS, Titball RW. ATP-binding cassette transporters are targets for the development of antibacterial vaccines and therapies. Infect Immun 72:6757-6763, 2004. (Pubitemid 39552342)
35. Jomaa M, Yuste J, Paton JC, Jones C, Dougan G, Brown JS. Antibodies to the iron uptake ABC transporter lipoproteins PiaA and PiuA promote opsonophagocytosis of Streptococcus pneumoniae. Infect Immun 73:6852-6859, 2005. (Pubitemid 41368853)
36. Kerr AR, Adrian PV, Estevao S, de Groot R, Alloing G, Claverys JP, Mitchell TJ, Hermans PW. The Ami-AliA/AliB permease of Streptococcus pneumoniae is involved in nasopharyngeal colonization but not in invasive disease. Infect Immun 72:3902-3906, 2004. (Pubitemid 38821904)
37. Hava DL, Camilli A. Large-scale identification of serotype 4 Streptococcus pneumoniae virulence factors. Mol Microbiol 45: 1389-1406, 2002. (Pubitemid 34595539)
38. Harland DN, Chu K, Haque A, Nelson M, Walker NJ, Sarkar-Tyson M, Atkins TP, Moore B, Brown KA, Bancroft G, Titball RW, Atkins HS. Identification of a LolC homologue in Burkholderia pseudomallei, a novel protective antigen for melioidosis. Infect Immun 75:4173-4180, 2007. (Pubitemid 47206316)
39. Malley R, Trzcinski K, Srivastava A, Thompson CM, Anderson PW, Lipsitch M. CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization. Proc Natl Acad Sci U S A 102(13):4848-4853, 2005. (Pubitemid 40471542)
40. McCool TL, Weiser JN. Limited role of antibody in clearance of Streptococcus pneumoniae in a murine model of colonization. Infect Immun 72:5807-5813, 2004. (Pubitemid 39303692)
41. van Rossum AM, Lysenko ES, Weiser JN. Host and bacterial factors contributing to the clearance of colonization by Streptococcus pneumoniae in a murine model. Infect Immun 73:7718-7726, 2005. (Pubitemid 41587678)
42. Malley R, Srivastava A, Lipsitch M, Thompson CM, Watkins C, Tzianabos A, Anderson PW. Antibody-independent, interleukin-17A-mediated, cross-serotype immunity to pneumococci in mice immunized intranasally with the cell wall polysaccharide. Infect Immun 74:2187-2195, 2006.
43. Trzcinski K, Thompson CM, Srivastava A, Basset A, Malley R, Lipsitch M. Protection against nasopharyngeal colonization by Streptococcus pneumoniae is mediated by antigen-specific CD4+ T cells. Infect Immun 76(6):2678-2684, 2008.
44. Arulanandam BP, Lynch JM, Briles DE, Hollingshead S, Metzger DW. Intranasal vaccination with pneumococcal surface protein A and interleukin-12 augments antibody-mediated opsonization and protective immunity against Streptococcus pneumoniae infection. Infect Immun 69:6718-6724, 2001. (Pubitemid 32995429)
45. Pimenta FC, Miyaji EN, Areas AP, Oliveira ML, de Andrade AL, Ho PL, Hollingshead SK, Leite LC. Intranasal immunization with the cholera toxin B subunit-pneumococcal surface antigen A fusion protein induces protection against colonization with Streptococcus pneumoniae and has negligible impact on the nasopharyngeal and oral microbiota of mice. Infect Immun 74:4939-4944, 2006. (Pubitemid 44157285)
46. Wu HY, Nahm MH, Guo Y, Russell MW, Briles DE. Intranasal immunization of mice with PspA (pneumococcal surface protein A) can prevent intranasal carriage, pulmonary infection, and sepsis with Streptococcus pneumoniae. J Infect Dis 175:839-846, 1997. (Pubitemid 27142957)